<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is one of the strongest negative prognostic factors for patients with Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (BCA) </plain></SENT>
<SENT sid="1" pm="."><plain>However, despite the importance of the metastatic process in BCA, the molecular basis of it remains poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>To search for cytogenetic events associated with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in regional or distant lymph nodes in BCA, we investigated 8 primary BCA and their <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> and compared them with 18 nonmetastatic BCA </plain></SENT>
<SENT sid="3" pm="."><plain>In metastatic primary BCA, we observed significantly more DNA gains on 3q (P = .013), 17q (P = .019), and 22q (P = .021) compared with nonmetastatic primary BCA </plain></SENT>
<SENT sid="4" pm="."><plain>No statistically significant correlation could be observed between DNA copy number changes and the histopathologic stage, grade, or survival (P &gt; .05) </plain></SENT>
<SENT sid="5" pm="."><plain>The most frequent alteration observed only in <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> but not in the related <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> was loss of 2q (5 of 8) </plain></SENT>
<SENT sid="6" pm="."><plain>Coamplification of 7p and chromosome 17 was found in 6 of 8 lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>A comparison of DNA copy number changes between <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and their corresponding <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> indicated a high degree of <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Fluorescence in situ hybridization analysis demonstrated the involvement of the Her-2/neu gene in primary BCA and its related <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Each of the investigated <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and related <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> also showed striking <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> with respect to Her-2/neu, with several areas displaying different levels of amplification </plain></SENT>
<SENT sid="10" pm="."><plain>In summary, our data indicate that DNA copy number changes on 2q, 3q, 7p, 17q, and 22q may be involved in the metastatic process in BCA </plain></SENT>
<SENT sid="11" pm="."><plain>Furthermore, the striking <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> that we found between primary BCA and its <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> may underlie BCA's poor responsiveness to therapy and could help explain why prognostic biomarkers measured exclusively in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> give an incomplete view of the biologic potential of BCA </plain></SENT>
</text></document>